Trademark: 79344191
Word
JULÄINE OF SWEDEN
Status
Pending
Status Code
681
Status Date
Wednesday, September 18, 2024
Serial Number
79344191
Mark Type
5
Filing Date
Friday, May 20, 2022
Published for Opposition
Tuesday, October 22, 2024

Trademark Owner History

Classifications
5 injectable dermal fillers; Pharmaceutical preparations in the nature of an injectable dermal filler; pharmaceutical preparations, namely, injectable poly-l-lactic acid for use in non-surgical restorative and beauty care treatment of wrinkles fine lines, folds, scars, lips, for face and body contouring, rejuvenating the skin and stimulation of collagen production; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Dermatological pharmaceutical products for use in filling out wrinkles, folds, scars, and lips, for face and body contouring, for rejuvenating the skin and for stimulation of collagen production; Dermatological pharmaceutical products, namely, biostimulatory injectable dermal filler implant; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for stimulation of collagen production; Dermatological pharmaceutical products, namely, injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable dermal implant for non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely injectable dermal implant for stimulation of collagen production
44 Dermatological services for treating skin conditions; beauty consultancy; beauty treatment services of the body and face; beauty care services; beauty information services; beauty therapy treatments, namely, cosmetic body care services in the nature of cosmetic skin care services, including non-surgical treatment of fine lines and wrinkles; Skin treatments, namely, the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinkles; beauty therapy treatment services, namely, non-invasive cosmetic body care services and cosmetic face care services; beauty therapy treatment services, namely cosmetic skincare treatment services in the nature of providing an injectable dermal filler to reduce the appearance of facial fine lines; cosmetic skin care services, namely, injection of dermal filling treatment for cosmetic skin care
10 Medical apparatus and devices, namely, injection needles prefilled with biostimulatory injectable dermal filler implant; Medical apparatus and devices, namely, injection needles prefilled with biostimulatory injectable dermal filler implant medical device; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles prefilled with injectable poly-llactic acid for stimulation of collagen production; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles prefilled with injectable dermal implant for stimulation of collagen production; medical therapy instruments in the nature of an injection needle; hypodermic injection apparatus, namely, hypodermic needles, medical syringes and disposable syringes; hypodermic syringes for injections for medical purposes; injection needles for medical use
JULAINE OF SWEDEN
"SWEDEN"

Trademark Events
Jul 7, 2022
Sn Assigned For Sect 66a Appl From Ib
Jul 8, 2022
New Application Office Supplied Data Entered
Jul 12, 2022
Application Filing Receipt Mailed
Mar 10, 2023
Assigned To Examiner
Mar 17, 2023
Non-Final Action Written
Mar 18, 2023
Non-Final Action (Ib Refusal) Prepared For Review
May 8, 2023
Refusal Processed By Mpu
May 8, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 31, 2023
Refusal Processed By Ib
Nov 7, 2023
Teas Response To Office Action Received
Nov 7, 2023
Correspondence Received In Law Office
Nov 8, 2023
Teas/Email Correspondence Entered
Jan 2, 2024
Notification Of Possible Opposition - Processed By Ib
Dec 13, 2023
Notification Of Possible Opposition Sent To Ib
Dec 13, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 9, 2024
Assigned To Examiner
Feb 13, 2024
Final Refusal Written
Feb 13, 2024
Final Refusal E-Mailed
Feb 13, 2024
Notification Of Final Refusal Emailed
Aug 13, 2024
Exparte Appeal Received At Ttab
Aug 13, 2024
Teas Request For Reconsideration Received
Aug 13, 2024
Ex Parte Appeal-Instituted
Aug 13, 2024
Jurisdiction Restored To Examining Attorney
Sep 16, 2024
Approved For Pub - Principal Register
Sep 16, 2024
Teas/Email Correspondence Entered
Sep 16, 2024
Correspondence Received In Law Office
Sep 16, 2024
Exparte Appeal Terminated

Trademark Alertz updated from USPTO on 2030-01-24